Cargando…
Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme
E1 enzymes activate ubiquitin (Ub) and ubiquitin-like modifiers (Ubls) in the first step of Ub/Ubl conjugation cascades and represent potential targets for therapeutic intervention in cancer and other life-threatening diseases. Here, we report the crystal structure of the E1 enzyme for the Ubl SUMO...
Autores principales: | Lv, Zongyang, Yuan, Lingmin, Atkison, James H., Williams, Katelyn M., Vega, Ramir, Sessions, E. Hampton, Divlianska, Daniela B., Davies, Christopher, Chen, Yuan, Olsen, Shaun K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279746/ https://www.ncbi.nlm.nih.gov/pubmed/30514846 http://dx.doi.org/10.1038/s41467-018-07015-1 |
Ejemplares similares
-
Structural insights into the mechanism and E2 specificity of the RBR E3 ubiquitin ligase HHARI
por: Yuan, Lingmin, et al.
Publicado: (2017) -
Crystal structures of an E1–E2–ubiquitin thioester mimetic reveal molecular mechanisms of transthioesterification
por: Yuan, Lingmin, et al.
Publicado: (2021) -
Structural insights into E1 recognition and the ubiquitin-conjugating activity of the E2 enzyme Cdc34
por: Williams, Katelyn M., et al.
Publicado: (2019) -
Crystal structures reveal catalytic and regulatory mechanisms of the dual-specificity ubiquitin/FAT10 E1 enzyme Uba6
por: Yuan, Lingmin, et al.
Publicado: (2022) -
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
por: Quambusch, Lena, et al.
Publicado: (2019)